Keenova Therapeutics plc
MNKTQDelisted Sep 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567892
Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Jul 23, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.
13F holders, Q2 2026
Institutional positions in Keenova Therapeutics plc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
MNKTQ is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 1
- 0 vs. Q1 2026
- Shares held
- 1
- 0 (0.0%) vs. Q1 2026
- Total value
- $0
- $0 vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNKTQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 4 | $12.5K |
| Q2 2023 | 36 | $12.4M |
| Q1 2023 | 45 | $75.2M |
| Q4 2022 | 47 | $80.5M |
| Q3 2022 | 3 | $889.0K |
| Q2 2022 | 3 | $1.21M |
| Q1 2022 | 10 | $8.07K |
| Q4 2021 | 12 | $8.09K |
| Q3 2021 | 10 | $4.15K |
| Q2 2021 | 11 | $64.2K |
| Q1 2021 | 21 | $84.3K |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Keenova Therapeutics plc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |